Ignite Creation Date:
2024-05-05 @ 4:42 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00299845
Status:
WITHDRAWN
Last Update Posted:
2012-10-11
First Post:
2006-03-06
Brief Title:
Randomized Trial for Pharmacogenomics-based Proton Pump Inhibitor Therapy in Children
Sponsor:
Osaka University
Organization:
Osaka University
Study Overview
Official Title:
None
Status:
WITHDRAWN
Status Verified Date:
2006-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Proton pump inhibitors are administered to children as off-label use in Japan The purpose of this study is to evaluate the effects of CYP2C19 genotypes on pharmacokinetic pharmacodynamic profiles of PPI in children The results will provide the beneficial information for the individualized medicine of PPI in children
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None